Hashimoto Takao, Arai Yusuke, Okada Hirofumi, Kikuno Muneaki, Sakamoto Hiroki, Matsunaga Kyosuke, Kohno Michihiro
Department of Neurosurgery, Tokyo Medical University.
Neurol Med Chir (Tokyo). 2025 Jan 15;65(1):1-8. doi: 10.2176/jns-nmc.2024-0059. Epub 2024 Nov 6.
The widespread adoption of preoperative embolization in highly vascularized brain tumors often involves the frequent use of Embosphere (Merit Medical Systems, South Jordan, Utah, USA). Nevertheless, inconsistency in size selection and dilution rates across different institutions requires comprehensive examination. This study explored the appropriate size and dilution rate of Embosphere microspheres. To assess catheter occlusion and Embosphere breakage, various dilutions (4-, 10-, 20-, 30-, and 60-fold) of Embosphere 300-500 and 500-700 μm were injected into the catheter in vitro. Results indicated that 20-fold or higher dilutions of Embosphere 300-500 μm and 30-fold or higher dilutions of Embosphere 500-700 μm showed no occlusion of the Excelsior SL-10 microcatheter (Stryker, Fremont, CA, USA) or Embosphere breakage. For embolization, to reduce the risk of Excelsior SL-10 occlusion further, a 30-fold dilution of Embosphere 300-500 μm and a 60-fold dilution of Embosphere 500-700 μm were employed. For 195 blood vessels in 107 patients (84 with meningioma and 23 with schwannoma), embolization was carried out using a 30-fold dilution of Embosphere 300-500 μm when the provocative test was negative and a 60-fold dilution of Embosphere 500-700 μm when the test was positive or when there was a risk of migration into neurotrophic vessels. Contrast-enhanced magnetic resonance imaging after embolization revealed a reduced enhancement effect in 69.1% of cases. Embolization using a 30-fold dilution of Embosphere 300-500 μm and a 60-fold dilution of Embosphere 500-700 μm with an Excelsior SL-10 catheter is safe and satisfactory, which minimizes microcatheter occlusion.
在血管高度丰富的脑肿瘤中,术前栓塞术的广泛应用常常涉及频繁使用Embosphere(美国犹他州南乔丹市美力医疗系统公司)。然而,不同机构在尺寸选择和稀释率方面存在不一致性,这需要进行全面研究。本研究探讨了Embosphere微球的合适尺寸和稀释率。为评估导管堵塞和Embosphere破裂情况,将Embosphere 300 - 500μm和500 - 700μm的各种稀释液(4倍、10倍、20倍、30倍和60倍)在体外注入导管。结果表明,Embosphere 300 - 500μm的20倍或更高稀释液以及Embosphere 500 - 700μm的30倍或更高稀释液未导致美国史赛克公司(加利福尼亚州弗里蒙特市)的Excelsior SL - 10微导管堵塞或Embosphere破裂。对于栓塞术,为进一步降低Excelsior SL - 10堵塞的风险,采用了Embosphere 300 - 500μm的30倍稀释液和Embosphere 500 - 700μm的60倍稀释液。对107例患者的195条血管(84例脑膜瘤患者和23例神经鞘瘤患者)进行栓塞时,激发试验阴性时使用Embosphere 300 - 500μm的30倍稀释液,试验阳性或有向神经营养血管迁移风险时使用Embosphere 500 - 700μm的60倍稀释液。栓塞后增强磁共振成像显示,69.1%的病例增强效果降低。使用Excelsior SL - 10导管,采用Embosphere 300 - 500μm的30倍稀释液和Embosphere 500 - 700μm的60倍稀释液进行栓塞是安全且令人满意的,可将微导管堵塞风险降至最低。